![Jennifer Pardi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ms. Jennifer E.
Pardi is a Managing Director, Global Head of Equity Capital Markets & Co-Head of US Securities at Canaccord Genuity LLC.
She is responsible for oversight of Canaccord Genuity’s global ECM activities, with a focus on driving coordination and best practices across all regions to drive optimal outcomes for our corporate and institutional clients.
Ms. Pardi was previously employed as an Independent Director by GreenLight Biosciences Holdings PBC.
She also served on the board at Environmental Impact Acquisition Corp.
She received her undergraduate degree from the University of Connecticut and an MBA from Suffolk University.
| Sociétés | Poste | Début |
|---|---|---|
Canaccord Genuity LLC
 Canaccord Genuity LLC Investment Banks/BrokersFinance Provides brokerage services | Directeur de la Recherche - Actions | 01/09/2003 |
| Sociétés | Poste | Fin |
|---|---|---|
| GREENLIGHT BIOSCIENCES HOLDINGS | Directeur/Membre du Conseil | 24/07/2023 |
| GREENLIGHT BIOSCIENCES HOLDINGS PBC | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 5 |
|---|---|
Suffolk University
 Suffolk University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Canaccord Genuity LLC
Canaccord Genuity LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Environmental Impact Acquisition Corp.
 Environmental Impact Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
GreenLight Biosciences Holdings PBC
 GreenLight Biosciences Holdings PBC BiotechnologyHealth Technology Operates as a biotechnology company that develops ribonucleic acid products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
